144 related articles for article (PubMed ID: 36440639)
1. Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Cobuccio LG; Laurent M; Gardiol C; Wampfler R; Poppert S; Senn N; Eperon G; Genton B; Locatelli I; de Vallière S
J Travel Med; 2023 Feb; 30(1):. PubMed ID: 36440639
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection.
Dinleyici EC; Eren M; Dogan N; Reyhanioglu S; Yargic ZA; Vandenplas Y
Parasitol Res; 2011 Mar; 108(3):541-5. PubMed ID: 20922415
[TBL] [Abstract][Full Text] [Related]
3. Exacerbated symptoms in Blastocystis sp.-infected patients treated with metronidazole: two case studies.
Rajamanikam A; Kumar S; Samudi C; Kudva M
Parasitol Res; 2018 Aug; 117(8):2585-2590. PubMed ID: 29872961
[TBL] [Abstract][Full Text] [Related]
4. High occurrence of Blastocystis sp. subtypes 1-3 and Giardia intestinalis assemblage B among patients in Zanzibar, Tanzania.
Forsell J; Granlund M; Samuelsson L; Koskiniemi S; Edebro H; Evengård B
Parasit Vectors; 2016 Jun; 9(1):370. PubMed ID: 27356981
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and clinical profile of adult patients with Blastocystis sp. infection in Barcelona, Spain.
Salvador F; Sulleiro E; Sánchez-Montalvá A; Alonso C; Santos J; Fuentes I; Molina I
Parasit Vectors; 2016 Oct; 9(1):548. PubMed ID: 27741951
[TBL] [Abstract][Full Text] [Related]
6. Blastocystis subtypes isolated from irritable bowel syndrome patients and co-infection with Helicobacter pylori.
El-Badry AA; Abd El Wahab WM; Hamdy DA; Aboud A
Parasitol Res; 2018 Jan; 117(1):127-137. PubMed ID: 29138961
[TBL] [Abstract][Full Text] [Related]
7. Intestinal parasite infections in a rural community of Rio de Janeiro (Brazil): Prevalence and genetic diversity of Blastocystis subtypes.
Barbosa CV; Barreto MM; Andrade RJ; Sodré F; d'Avila-Levy CM; Peralta JM; Igreja RP; de Macedo HW; Santos HLC
PLoS One; 2018; 13(3):e0193860. PubMed ID: 29522552
[TBL] [Abstract][Full Text] [Related]
8. Increase number of mitochondrion-like organelle in symptomatic Blastocystis subtype 3 due to metronidazole treatment.
Raman K; Kumar S; Chye TT
Parasitol Res; 2016 Jan; 115(1):391-6. PubMed ID: 26481491
[TBL] [Abstract][Full Text] [Related]
9. Detection of Blastocystis sp. and Dientamoeba fragilis using conventional and molecular methods in patients with celiac disease.
Mızrak M; Sarzhanov F; Demirel F; Dinç B; Filik L; Dogruman-Al F
Parasitol Int; 2024 Aug; 101():102888. PubMed ID: 38499283
[TBL] [Abstract][Full Text] [Related]
10. Investigation of intestinal parasites by conventional and molecular methods in children with gastrointestinal system complaints.
Özkan-Ahmetoğlu M; Demirel F; Taşar MA; Dinç B; Sarzhanov F; Dogruman-Al F
Parasitol Res; 2023 Jun; 122(6):1361-1370. PubMed ID: 37036521
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the presence of Blastocystis spp. in stool samples with microscopic, culture and molecular methods].
Adıyaman Korkmaz G; Doğruman Al F; Mumcuoğlu İ
Mikrobiyol Bul; 2015 Jan; 49(1):85-97. PubMed ID: 25706734
[TBL] [Abstract][Full Text] [Related]
12. Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both conventional and molecular methods.
Sarzhanov F; Dogruman-Al F; Santin M; Maloney JG; Gureser AS; Karasartova D; Taylan-Ozkan A
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009779. PubMed ID: 34613993
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of intestinal parasites, with emphasis on the molecular epidemiology of Giardia duodenalis and Blastocystis sp., in the Paranaguá Bay, Brazil: a community survey.
Seguí R; Muñoz-Antoli C; Klisiowicz DR; Oishi CY; Köster PC; de Lucio A; Hernández-de-Mingo M; Puente P; Toledo R; Esteban JG; Carmena D
Parasit Vectors; 2018 Aug; 11(1):490. PubMed ID: 30165880
[TBL] [Abstract][Full Text] [Related]
14. No advantage for antibiotic treatment over placebo in Blastocystis hominis-positive children with recurrent abdominal pain.
Heyland K; Friedt M; Buehr P; Braegger CP
J Pediatr Gastroenterol Nutr; 2012 May; 54(5):677-9. PubMed ID: 22002479
[TBL] [Abstract][Full Text] [Related]
15. Molecular and descriptive epidemiology of intestinal protozoan parasites of children and their pets in Cauca, Colombia: a cross-sectional study.
Villamizar X; Higuera A; Herrera G; Vasquez-A LR; Buitron L; Muñoz LM; Gonzalez-C FE; Lopez MC; Giraldo JC; Ramírez JD
BMC Infect Dis; 2019 Feb; 19(1):190. PubMed ID: 30808303
[TBL] [Abstract][Full Text] [Related]
16. Blastocystis sp. subtype 2 detection during recurrence of gastrointestinal and urticarial symptoms.
Vogelberg C; Stensvold CR; Monecke S; Ditzen A; Stopsack K; Heinrich-Gräfe U; Pöhlmann C
Parasitol Int; 2010 Sep; 59(3):469-71. PubMed ID: 20363362
[TBL] [Abstract][Full Text] [Related]
17. Distribution of Blastocystis subtypes isolated from humans from an urban community in Rio de Janeiro, Brazil.
Valença Barbosa C; de Jesus Batista R; Pereira Igreja R; d'Avila Levy CM; Werneck de Macedo H; Carneiro Santos HL
Parasit Vectors; 2017 Oct; 10(1):518. PubMed ID: 29070053
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France.
El Safadi D; Cian A; Nourrisson C; Pereira B; Morelle C; Bastien P; Bellanger AP; Botterel F; Candolfi E; Desoubeaux G; Lachaud L; Morio F; Pomares C; Rabodonirina M; Wawrzyniak I; Delbac F; Gantois N; Certad G; Delhaes L; Poirier P; Viscogliosi E
BMC Infect Dis; 2016 Aug; 16(1):451. PubMed ID: 27566417
[TBL] [Abstract][Full Text] [Related]
19. Children of Senegal River Basin show the highest prevalence of Blastocystis sp. ever observed worldwide.
El Safadi D; Gaayeb L; Meloni D; Cian A; Poirier P; Wawrzyniak I; Delbac F; Dabboussi F; Delhaes L; Seck M; Hamze M; Riveau G; Viscogliosi E
BMC Infect Dis; 2014 Mar; 14():164. PubMed ID: 24666632
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
